{"prompt": "['Date:', '/', '/ 2017', 'Center Number:', '/', '/', '/', 'Participant N\u00b0:', '/', 'MM DD', 'Adelphi', 'ADELPHI VALUES', 'Appendix 4: Case Report Form', 'PARTICIPANT CASE REPORT FORM (CRF)', 'TO BE COMPLETED BY THE RECRUITING PHYSICIAN', '(Please complete a separate form for each patient recruited to the study)', 'Physician Details', 'Name (printed):', 'Date of form completion:', '/', '/', '/', '/', '/', '/ / /', 'Month', 'Day', 'Year', 'What is your job title/field of specialty?', 'Please specify:', 'Please sign here:', 'INCLUSION CRITERIA', 'Yes', 'No', '1. Participant has received oral or injectable systemic corticosteroids in the last', '1', '2', '4 weeks (28 days) for the management of their nasal polyps', '2. Participant has a clinical diagnosis of bilateral nasal polyps as diagnosed', '1', '2', 'by endoscopy or CT scan.', '3. Participant is aged 18 or over.', '1', '2', '4. Participant has severe nasal polyp symptoms as defined as a patient-', 'reported nasal obstruction Visual Analogue Score (VAS) of >5 (Please ask', '1', '2', 'patient to complete Appendix 1 of this protocol).', '5. Participant has had at least one previous surgery in the past ten years for', 'the removal of nasal polyps. Surgery in this case is defined as any', 'procedure involving instruments with resulting incision and removal of polyp', '1', '2', 'tissue from the nasal cavity (polypectomy).', '6. Participant is currently an eligible candidate for polypectomy defined by:', 'c) An overall patient-reported VAS symptom score of >7 (Appendix 2 of this', 'protocol).', '1', '2', 'AND', 'd) An endoscopic bilateral nasal polyp score of at least 5 out of a', 'maximum score of 8 (with a minimum score of 2 in each nasal cavity) (', 'CGI-501 E010', 'Page 38 of 131', 'Effective: 20 Jan 2017']['Date:', '/', '/ 2017', 'Center Number:', '/', '/', '/', 'Participant N\u00b0:', 'MM', 'DD', 'Adelphi', 'ADELPHI VALUES', 'INCLUSION CRITERIA', 'Yes', 'No', 'e) Appendix 3 of this protocol).', '7. Participant has symptoms consistent with chronic rhinosinusitis.', '1', '2', '8.', 'Participant is currently receiving intranasal corticosteroids for management', '1', '2', 'of their nasal polyps.', '8. Participant is willing to participate in the study and provide informed consent.', '1', '2', '9. Participant is an English speaker and is able to read, write and fully', '1', '2', 'understand the English language.', '10. Participant is willing to and able to attend and participate in a 120-minute', 'interview to discuss their experiences of nasal polyps and give feedback on', '1', '2', 'several symptom/impact questionnaires.', 'Es If ONE of the above answers is NO, the patient CANNOT be included in the study', 'EXCLUSION CRITERIA', 'Yes', 'No', '1. Participant has a diagnosis of cystic fibrosis.', '1', '2', '2. Participant has a diagnosis of eosinophilic granulomatosis with polyangitis', \"(also known as Churg Strauss syndrome), Young's, Kartagener's or\", '1', '2', 'dyskinetic ciliary syndromes).', '3. Participant has a diagnosis of antrochoanal polyps.', '1', '2', '4. Participant has a diagnosis of nasal septal deviation occluding one nostril.', '1', '2', '5. Participant has acute sinusitis or upper respiratory tract infection or has had', '1', '2', 'had acute sinusitis or upper respiratory tract infection in the last two weeks.', '6. Participant has ongoing rhinitis medicamentosa (rebound or chemical', '1', '2', 'induced rhinitis).', '7. Participant has had an asthma exacerbation requiring admission to hospital', '1', '2', 'in the past four weeks.', '8. Participant is currently or has previously taken part in a clinical trial for nasal', '1', '2', 'polyps.', '9. Participant is unwilling or unable to comply with the requirements of the study or', 'has a physical or mental condition or learning difficulties that, in the opinion of the', '1', '2', \"physician, may affect the participant's ability to participate in the study, the\", 'GK7818Av7_0', 'Page 39 of 131', 'Effective: 20 Jan 2017']\n\n###\n\n", "completion": "END"}